Companies: 10,795·Total market cap: $144.5T
MorphoSys AG

MorphoSys AG

MORNASDAQHealthcare
$18.96
+$0.45(+2.43%)
Market Cap$2.9B
P/E Ratio
52W High$19.5
52W Low$4.185
Overview

MorphoSys AG(MOR)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MOR · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-3.16mor eps ttm · mor earnings per shareEarnings history
PE Ratio (TTM)mor pe ratio ttm · mor price to earningsPE Ratio deep dive
Revenue (TTM)$203.6Mmor revenue ttm · mor annual revenueFull revenue history
Dividend Yield不分红does mor pay dividends · mor dividend yieldDividend history
Shares Outstanding137.2Mmor shares outstanding · mor floatShares outstanding history
Next EarningsTBAmor earnings date · mor next earningsEarnings history

财务快照

完整财报
FY 2023Revenue$238.3M▼ 14.37% YoY
202120222023
morphosys ag revenue · mor revenue 2023
FY 2023Net Income-$189.7M▼ 25.60% YoY
202120222023
morphosys ag net income · mor profit 2023
FY 2023EPS$-1.38▼ 25.45% YoY
202120222023
mor eps · morphosys ag earnings per share 2023
TTM:Revenue: $203.6MNet Income: -$460.3MEPS: $-3.16View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy10 位分析师is mor a buy · mor analyst rating
Strong Buy
0
Buy
5
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$18.96Current
$Avg Target
$High
mor price target · mor 12 month forecast

合计: 10 · 买入占比: 50.0%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+2.43%
3M+3.10%
YTD+96.68%
1Y+155.53%
5Y-34.39%

关于 MorphoSys AG

CEOArkadius Pichota
IPO DateApr 19, 2018
Employees464
CountryDE

MorphoSys AG is a commercial-stage biopharmaceutical company dedicated to the discovery, advancement, and marketing of innovative therapeutic antibodies aimed at treating cancer and autoimmune disorde…

what is morphosys ag · mor stock overview · morphosys ag company profile · who is morphosys ag ceo · mor NASDAQ · morphosys ag headquarters · morphosys ag business segments

关于股票概览与关键数据

MorphoSys AG(MOR)是 Biotechnology 行业的 Healthcare 类公司,于 Apr 19, 2018 在 NASDAQ 上市。截至最近交易日,MOR 股价为 $18.96,市值约为 $2.9B。过去12个月累计回报 +155.53%,年初至今回报 +96.68%。

根据 10 位华尔街分析师,MorphoSys AG 股票共识评级为Buy,12个月平均目标价为 $—。2023 财年 MorphoSys AG 营收 $238.3M,净利润 -$189.7M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,MorphoSys AG(MOR)股价为 $18.96,在 NASDAQ 上市,52周区间为 $4.18 – $19.50。

MOR 最新股价MOR quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议